Cytomorphological and histological studies on the urothelium during and after chemoimmune prophylaxis
- 1 April 1984
- journal article
- research article
- Published by Springer Nature in Urological Research
- Vol. 12 (2) , 129-133
- https://doi.org/10.1007/bf00257179
Abstract
During and after chemoimmune prophylaxis with i.v. cyclophosphamide (CTX) and both intravesical and systemic BCG-treatment, the bladder mucosa is prone to morphological changes which might resemble tumor recurrences. Therefore, morphological parameters which can discriminate between treatment effects and tumor recurrences are of interest. In a prospective study, routine cytology, determination of granulocytes, lymphocytes, and macrophages in the urine sediment as well as flow-cytophotometry (FCM) for DNA analysis were performed before, during, and after chemoimmune prophylaxis. In addition, bladder biopsies and all recurrent tumors were histologically analysed. Our results show that FCM is the best method for monitoring the bladder mucosa for recurrent tumors during treatment. After termination of BCG, it takes at least 4 months for cytological normalization to take place. Urine excretion of granulocytes, lymphocytes, and macrophages does not correlate with this process. Histological alterations during treatment are demonstrated; their normalization requires at least 3 months. In 10% of the patients chronic inflammatory lesions (“pseudotumors”) develop.This publication has 8 references indexed in Scilit:
- Chemoimmune Prophylaxis of Superficial Bladder CancerJournal of Urology, 1983
- Chemoimmune prophylaxis of superficial bladder tumors: Results after treatment of 130 patients in 4 yearsUrological Research, 1983
- Bladder Cancer ImmunotherapyJournal of Urology, 1982
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- Improved application of impulse cytophotometry for the diagnosis of urinary bladder carcinomaUrological Research, 1982
- BCG immunotherapy of bladder cancer: Inhibition of tumor recurrence and associated immune responsesCancer, 1981
- Automated flow cytometry to monitor intravesical BCG therapy of superficial bladder cancerUrology, 1981
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976